Shionogi & Co., Ltd. Decides to Upgrade to Next-Generation Commercial Foundation, Veeva Vault CRM

Veeva Japan K.K. (Headquarters: Shibuya-ku, Tokyo; General Manager: Hirotaka Chiba; hereinafter "Veeva") announces that Shionogi & Co., Ltd. (Headquarters: Osaka City, Osaka; Chairman and President, CEO: Isao Teshirogi; hereinafter "Shionogi") has decided to migrate to Veeva's next-generation CRM, "Veeva Vault CRM." By leveraging the unified platform, agentic AI, and other advanced technologies of Veeva Vault CRM, Shionogi will strongly promote the business model transformation and shift to a data-driven organization outlined in its medium-term management plan.

Regarding this decision, Mr. Satoru Yoshimoto, Senior Executive Officer and Senior Vice President of the Healthcare Strategy Division at Shionogi, stated: "In our medium-term management plan, we have set goals for 'Global Business Model and Operation Transformation' and 'Value Creation through Data Utilization Promotion,' and we are challenging ourselves to undertake a fundamental reform from the core of our management. In recent years, due to the sophistication of our business portfolio, including M&A, and intensified global competition, the quality and speed of transformation required of companies are at a different level than before. To achieve sustainable growth in this environment, establishing a foundation that links company-wide decision-making and execution in real-time is essential. From this perspective, migrating to Veeva Vault CRM, which is widely adopted by major pharmaceutical companies and emerging biopharmas worldwide, is not just a system update. We position it as a strengthening of the management foundation for our company to advance to the next stage of growth and a strategic decision to create a competitive advantage."

Mr. Yoshimoto further added, "In this migration, with an eye on the major transformation of integrating our head office with Torii Pharmaceutical Co., Ltd., we will build a mechanism where sales, marketing, and medical affairs utilize a common database to re-evaluate all customer touchpoints comprehensively. This will enable real-time visualization of each individual's activities in the field, leading to optimal actions for the entire organization. Furthermore, by combining agentic AI on this foundation, we will move away from operations dependent on conventional experience and intuition to achieve more advanced and reproducible decision-making and execution. As a result, we will not only maximize integration synergies but also evolve our field operations themselves, sustainably enhancing our competitiveness."

Hirotaka Chiba, General Manager of Veeva Japan, commented: "We are greatly honored that Shionogi has chosen Veeva Vault CRM as a crucial management foundation as they challenge themselves to achieve management transformation at an unprecedented speed. We are confident that our next-generation platform, Veeva Vault CRM, and its natively integrated agentic AI can truly support Shionogi's goal of transforming into a data-driven organization and evolving their field operations. We are delighted to further deepen our partnership through this migration and contribute to maximizing integration synergies and creating new value."

[About Veeva Systems]
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

[Veeva Forward-looking Statements]
This release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2026, which you can find here (a summary of risks which may impact our business can be found on pages 13 and 14), and in our subsequent SEC filings, which you can access at sec.gov.